Test may someday help predict diabetes risk
All women, regardless of risk, should focus on preventing diabetes.
"LPIR correctly indicated higher risk in almost an additional 6% of those women who developed type 2 diabetes within the study period," says fellow study author, Dr. Paulo Harada, cardiologist and research collaborator for the Center for Lipid Metabolomics at Harvard-affiliated Brigham and Women's Hospital. At the same time, it identified almost 8% more women who were at lower risk of developing type 2 diabetes.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online Plus (HHO+) to unlock expert-backed health insights, personalized tools, and exclusive resources to feel your best every day.
Here’s what you get with your HHO+ membership:
- Unlimited access to all Harvard Health Online content
- 4 expertly curated newsletters delivered monthly
- Customized website experience aligned to your health goals
- In-depth health guides on topics like sleep, exercise, and more
- Interactive features like videos and quizzes
- Members-only access to exclusive articles and resources
I’d like to subscribe to HHO+ for $4.99/month to access expert-backed content to help make smart, informed decisions about my well-being.
Sign Me UpAlready a member? Login ».
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
